Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin's disease: A review

Clinical Epidemiology

Volumn 3, Issue 1, 2011, Pages 7-19

  Langagergaard, Vivian ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Birth outcome; Breast cancer; Epidemiology; Hodgkin's disease; Melanoma

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER RADIOTHERAPY; CONGENITAL MALFORMATION; HIGH RISK PREGNANCY; HODGKIN DISEASE; HUMAN; LOW BIRTH WEIGHT; MELANOMA; PREGNANCY OUTCOME; PREMATURE LABOR; PREVALENCE; REVIEW; RISK FACTOR; STILLBIRTH; SYSTEMATIC REVIEW;

EID: 79251534983     PISSN: None     EISSN: 11791349     Source Type: Book Series    
DOI: 10.2147/CLEP.S12190     Document Type: Review

References (71)

1. Dow KH, Harris JR, Roy C. Pregnancy after breast-conserving surgery and radiation therapy for breast cancer. J Natl Cancer Inst Monogr. 1994; (16):131-137.
2. Statistics Denmark. FOD11: Mean age of Danish women at first delivery. http://www.statistikbanken.dk/FOD11/. Accessed Mar 15 2010.
3. Nye tal fra Sundhedsstyrelsen 2009: Cancerregisteret 2008. http://www.sst.dk/publ/Publ2009/DOKU/cancerreg/cancerregisteret_2008.pdf. Accessed Mar 15 2010.
4. Fisher PM, Hancock BW. Hodgkin's disease in the pregnant patient. Br J Hosp Med. 1996;56(10):529-532.
5. Koren G, Lishner M, Zemlickis D. Cancer in pregnancy: identification of unanswered questions on maternal and fetal risks. In: Koren G, Lishner M, Farine D, editors. Cancer in pregnancy: Maternal and fetal risks. Cambridge: Cambridge University Press; 1996:3-14.
6. Rørth M, Storm H. Kræftsygdomme. Onkologi. Ringborg U, Henriksson R, Friberg S, editors. 2004.
7. Kroman N, Jensen MB, Melbye M, Wohlfahrt J, Mouridsen HT. Should women be advised against pregnancy after breast-cancer treatment? Lancet. 1997;350(9074):319-322.
8. Blakely LJ, Buzdar AU, Lozada JA, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004;100(3):465-469.
9. Kroman N, Jensen MB, Wohlfart J, Ejlertsen B; Danish Breast Cancer Cooperative Group. Pregnancy after treatment of breast cancer - a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol. 2008;47(4):545-549.
10. Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001;7(4):394-403.
11. Kroman NT, Lidegaard O, Kvistgaard ME. Breast cancer - a lifestyle disease?. Ugeskr Laeger. 2005;167(49):4636-4641.
12. Weisz B, Meirow D, Schiff E, Lishner M. Impact and treatment of cancer during pregnancy. Expert Rev Anticancer Ther. 2004;4(5):889-902.
13. Bevona C, Sober AJ. Melanoma incidence trends. Dermatol Clin. 2002; 20(4):589-595, vii.
14. Van der Horst M, Winther JF, Olsen JH. Cancer incidence in the age range 0-34 years: historical and actual status in Denmark. Int J Cancer. 2006;118(11):2816-2826.
15. Lishner M. Cancer in pregnancy. Ann Oncol. 2003;14 Suppl 3: iii31-iii36.
16. Melbye M, Adami H-O. Hodgkin's lymphoma. In: Adami H-O, Hunter D, Trichopoulos D, editors. Textbook of Cancer Epidemiology. New York: Oxford University Press; 2002:520-534.
17. Cancer incidens i Danmark 2000. Sundhedsstyrelsen. 2004. http://www.sst.dk/publ/tidsskrifter/nyetal/pdf/2004/17_04.pdf. Accessed Mar 15 2010.
18. Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184(7):1504-1512.
19. Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer. 1992;65(1):114-117.
20. Savitz DA, Hertz-Picciotto I, Poole C, Olshan AF. Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev.2002;24(2):91-101.
21. Sutton R, Buzdar AU, Hortobagyi GN. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer. 1990;65(4): 847-850.
22. Malamos NA, Stathopoulos GP, Keramopoulos A, Papadiamantis J, Vassilaros S. Pregnancy and offspring after the appearance of breast cancer. Oncology. 1996;53(6):471-475.
23. Langagergaard V, Gislum M, Skriver MV, et al. Birth outcome in women with breast cancer. Br J Cancer. 2006:94(1):142-146.
24. Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer - a population-based cohort study from Sweden. PLoS Med. 2006;3(9):e336.
25. Zemlickis D, Lishner M, Degendorfer P, et al. Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol. 1992; 166(3):781-787.
26. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283-291.
27. Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999;17(3):855-861.
28. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol. 2005; 23(18):4192-4197.
29. Hansen D, Moller H, Olsen J. Severe periconceptional life events and the sex ratio in offspring: follow up study based on five national registers. BMJ. 1999;319(7209):548-549.
30. Nagarajan R, Robison LL. Pregnancy outcomes in survivors of childhood cancer. J Natl Cancer Inst Monogr. 2005;(34):72-76.
31. Byrne J, Rasmussen SA, Steinhorn SC, et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet. 1998;62(1):45-52.
32. Hawkins MM. Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst. 1991;83(22):1643-1650.
33. Winther JF, Boice JD Jr, Thomsen BL, Schull WJ, Stovall M, Olsen JH. Sex ratio among offspring of childhood cancer survivors treated with radiotherapy. Br J Cancer. 2003;88(3):382-387.
34. Langagergaard V, Puho EH, Lash TL, Nørgård B, Sørensen HT. Birth outcome in Danish women with cutaneous malignant melanoma. Melanoma Res. 2007;17(1):31-36.
35. O'Meara AT, Cress R, Xing G, Danielsen B, Smith LH. Malignant melanoma in pregnancy. A population-based evaluation. Cancer. 2005; 103(6):1217-1226.
36. Ravid M, Lishner M, Zemlickis D, Koren G. Malignant melanoma and pregnancy. In: Koren G, Lishner M, Farine D, editors. Cancer in Pregnancy: Maternal and Fetal Risks. Cambridge: Cambridge University Press; 1996:134-142.
37. Janov AJ, Anderson J, Cella DF, Zuckerman E, Kornblith AB, Holland JC, et al. Pregnancy outcome in survivors of advanced Hodgkin disease. Cancer. 1992;70(3):688-692.
38. Swerdlow AJ, Jacobs PA, Marks A, et al. Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: an investigation including chromosome examinations. Br J Cancer. 1996;74(2):291-296.
39. Holmes GE, Holmes FF. Pregnancy outcome of patients treated for Hodgkin's disease: a controlled study. Cancer. 1978;41(4):1317-1322.
40. Signorello LB, Cohen SS, Bosetti C, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst. 2006;98(20):1453-1461.
41. Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol. 2002;187(4):1070-1080.
42. Langagergaard V, Horvath-Puho E, Nørgaard M, Nørgård B, Sørensen HT. Hodgkin's disease and birth outcome: a Danish nationwide cohort study. Br J Cancer. 2008;98:183-188.
43. Lambe M, Ekbom A. Cancers coinciding with childbearing: delayed diagnosis during pregnancy? BMJ. 1995;311(7020):1607-1608.
44. Zhu JL, Basso O, Hasle H, Winther JF, Olsen JH, Olsen J. Do parents of children with congenital malformations have a higher cancer risk? A nationwide study in Denmark. Br J Cancer. 2002;87(5):524-528.
45. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Maternal fever and birth outcome: a prospective study. Teratology. 1998; 58(6):251-257.
46. Tikkanen J, Heinonen OP. Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring. Eur J Epidemiol. 1991;7(6):628-635.
47. Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. Maternal nutrition and fetal development. J Nutr. 2004;134(9):2169-2172.
48. McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med. 1999;340(16):1234-1238.
49. Barker DJP. Fetal origins of coronary heart disease. BMJ. 1995; 311(6998):171-174.
50. Hedegaard M, Henriksen TB, Sabroe S, Secher NJ. Psychological distress in pregnancy and preterm delivery. BMJ. 1993;307(6898):234-239.
51. Hedegaard M, Henriksen TB, Secher NJ, Hatch MC, Sabroe S. Do stressful life events affect duration of gestation and risk of preterm delivery? Epidemiology. 1996;7(4):339-345.
52. Hansen D, Lou HC, Olsen J. Serious life events and congenital malformations: a national study with complete follow-up. Lancet. 2000; 356(9233):875-880.
53. Moran BJ, Yano H, Al Zahir N, et al. Conflicting priorities in surgical intervention for cancer in pregnancy. Lancet Oncol. 2007;8(6): 536-544.
54. Weisz B, Schiff E, Lishner M. Cancer in pregnancy: maternal and fetal implications. Hum Reprod Update. 2001;7(4):384-393.
55. Nisce LZ, Tome MA, He S, Lee BJ III, Kutcher GJ. Management of coexisting Hodgkin's disease and pregnancy. Am J Clin Oncol. 1986; 9(2):146-151.
56. Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6(5):328-333.
57. Woo SY, Fuller LM, Cundiff JH, et al. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1992;23(2):407-412.
58. Li FP, Gimbrere K, Gelber RD, et al. Outcome of pregnancy in survivors of Wilms' tumor. JAMA. 1987;257(2):216-219.
59. Chiarelli AM, Marrett LD, Darlington GA. Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology. 2000; 11(2):161-166.
60. Boice JD Jr, Tawn EJ, Winther JF, et al. Genetic effects of radiotherapy for childhood cancer. Health Phys. 2003;85(1):65-80.
61. Winther JF, Boice Jr JD, Frederiksen K, et al. Radiotherapy for childhood cancer and risk for congenital malformations in offspring: a populationbased cohort study. Clin Genet. 2009;75:50-56.
62. Schull WJ, Neel JV. Radiation and the sex ratio in man. Science. 1958; 128(3320):343-348.
63. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer. 1989; 43(3):399-402.
64. Winther JF, Boice Jr JD, Svendsen AL, et al. Spontaneous abortion in a Danish population-based cohort of childhood cancer survivors. J Clin Oncol. 2008;26:4340-4346.
65. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7(6):535-543.
66. Schmidt KL, Andersen CY, Loft A, Byskov AG, Ernst E, Andersen AN. Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation. Hum Reprod. 2005;20(12):3539-3546.
67. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol. 1989;16(5):337-346.
68. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2(3):173-177.
69. Bath LE, Wallace WH, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG. 2002;109(2):107-114.
70. Lo PA, Ruvolo G, Gancitano RA, Cittadini E. Ovarian function following radiation and chemotherapy for cancer. Eur J Obstet Gynecol Reprod Biol. 2004;113(Suppl 1):S33-S40.
71. Tewari K, Bonebrake RG, Asrat T, Shanberg AM. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet. 1997; 350(9072):183.